What Is the Clinical Impact of the Genetic Polymorphism Observed with the Effectiveness of some P2Y12 Inhibitors?

August 3, 2021
The association of genetic polymorphisms and P2Y12 inhibitors in regards to efficacy for patients with ischemic stroke or transient ischemic attack (TIA) remains controversial. Drs. Deepak Bhatt of Brigham and Women’s Hospital and Natalie Kreitzer of the University of Cincinnati discuss key perspectives from a neurocritical, emergency medicine, and stroke perspective related to this important area of medicine.
0 Comments

CT Angiography - What Should the Rest of Us Know?

June 8, 2021
CT Angiography of the head and neck has become a standard in the Emergency Department as part of the initial workup of a patient with a suspected stroke, but they are challenging to interpret.
2 Comments

What Should All Physicians Know About Endovascular Stroke Care?

December 4, 2020
Endovascular stroke care is the criterion standard for LVO treatment, yet not everyone is fluent with data and techniques.  
0 Comments

What Lessons Have You Learned About Endovascular Therapy in COVID Patients and What Should We All Know?

December 2, 2020
Acute interventional management during the COVID pandemic requires a change of focus and practice. Challenges abound and danger exists at every decision point.
0 Comments
RSS
123
Categories
More Entries